ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 108 filers reported holding ADICET BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $301,722 | +17.5% | 249,357 | +128.3% | 0.00% | – |
| Q1 2024 | $256,716 | +230.3% | 109,241 | +709.6% | 0.00% | – |
| Q1 2023 | $77,720 | -93.3% | 13,493 | -89.6% | 0.00% | -100.0% |
| Q4 2022 | $1,156,952 | +553.6% | 129,413 | +853.9% | 0.01% | +100.0% |
| Q1 2021 | $177,000 | -66.8% | 13,567 | -64.2% | 0.00% | -62.5% |
| Q4 2020 | $533,000 | – | 37,915 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $18,911,542 | 6.16% |
| Foresite Capital Management V, LLC | 558,636 | $4,994,206 | 3.88% |
| COWEN AND COMPANY, LLC | 3,143,608 | $28,103,855 | 2.94% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $5,185,200 | 1.94% |
| JOHNSON & JOHNSON | 728,944 | $6,517 | 1.90% |
| DAFNA Capital Management LLC | 631,554 | $5,646,093 | 1.59% |
| Orbimed Advisors | 7,447,140 | $66,577,432 | 1.27% |
| EcoR1 Capital, LLC | 3,560,700 | $31,832,658 | 0.97% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $5,364,000 | 0.78% |
| RTW INVESTMENTS, LP | 4,241,472 | $37,918,760 | 0.77% |